found that BUB1 kinase promotes the advancement and multiplication of human bladder cancer (BCa) by modulating the transcriptional activation of STAT3 signaling, making it a potential target for BCa therapy (61). The gene discussed is STAT3; the disease is urinary bladder carcinoma.